Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
KALETRA ABBVIE CORPORATION Resolved 100MG 400MG Updated Report 2022-05-26 159917
SALOFALK APTALIS PHARMA CANADA ULC Actual shortage 1G Updated Report 2022-05-26 161258
ADMELOG SANOFI-AVENTIS CANADA INC Actual shortage 100UNIT Updated Report 2022-05-26 160685
ROPIVACAINE HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Actual shortage 10MG Updated Report 2022-05-25 158396
PROSTIN VR STERILE SOLUTION PFIZER CANADA ULC Resolved 500MCG Updated Report 2022-05-25 154147
MYLAN-CLOBETASOL CREAM MYLAN PHARMACEUTICALS ULC Resolved 0.05% Updated Report 2022-05-25 160856
MYLAN-NAPROXEN/ESOMEPRAZOLE MR MYLAN PHARMACEUTICALS ULC Actual shortage 20MG 500MG Updated Report 2022-05-25 152651
MYLAN-TADALAFIL MYLAN PHARMACEUTICALS ULC Actual shortage 20MG Updated Report 2022-05-25 152654
MYLAN-VARDENAFIL MYLAN PHARMACEUTICALS ULC Actual shortage 10MG Updated Report 2022-05-25 157908
MYLAN-ATOVAQUONE/PROGUANIL MYLAN PHARMACEUTICALS ULC Anticipated shortage 100MG 250MG New Report 2022-05-25 161243

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ METHYLPHENIDATE SR SANDOZ CANADA INCORPORATED Discontinued 20MG New Report 2022-05-24 161221
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 200MG New Report 2022-05-24 161216
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 100MG New Report 2022-05-24 161211
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 25MG New Report 2022-05-24 161206
IMOVANE SANOFI-AVENTIS CANADA INC To be discontinued 5.0MG Updated Report 2022-05-16 160688
HEPTOVIR GLAXOSMITHKLINE INC To be discontinued 5MG New Report 2022-05-13 160503
HEPTOVIR GLAXOSMITHKLINE INC To be discontinued 100MG New Report 2022-05-13 160500
APO-BICALUTAMIDE APOTEX INC Discontinued 50MG Updated Report 2022-05-13 157376
ISOPTO CARPINE NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 4% New Report 2022-05-11 160361
RITALIN 10MG NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 10MG Updated Report 2022-05-11 154449
VENTOLIN NEBULES P.F. - 5MG/2.5ML GLAXOSMITHKLINE INC To be discontinued 5MG Updated Report 2022-05-11 130636
VENTOLIN NEBULES P.F. - 2.5MG/2.5ML GLAXOSMITHKLINE INC To be discontinued 2.5MG Updated Report 2022-05-11 130633
ONDANSETRON INJECTION, USP MYLAN PHARMACEUTICALS ULC Discontinued 2MG New Report 2022-05-11 160318
ONDANSETRON INJECTION, USP MYLAN PHARMACEUTICALS ULC Discontinued 2MG New Report 2022-05-11 160323
INTEGRILIN MERCK CANADA INC To be discontinued 2MG Updated Report 2022-05-10 155794
ZEPATIER MERCK CANADA INC To be discontinued 100MG 50MG Updated Report 2022-05-06 158741
ZOSTAVAX II MERCK CANADA INC To be discontinued 19400PFU New Report 2022-04-26 159386
DEXTROSE INJECTION USP ICU MEDICAL CANADA INC To be discontinued 700MG New Report 2022-04-21 159241
CODEINE PHOSPHATE INJECTION USP SANDOZ CANADA INCORPORATED Discontinued 30MG New Report 2022-04-20 159064
SANDOZ PIOGLITAZONE SANDOZ CANADA INCORPORATED Discontinued 15MG New Report 2022-04-20 159061